Enriqueta Felip, MD, PhD, discusses the phase 3 3475A-D77 study of subcutaneous pembrolizumab plus chemotherapy in metastatic non–small cell lung cancer.
Pat Gulhati, MD, PhD, discusses findings from a comprehensive analysis of genetic, immunological, and signaling pathway variations in pancreatic cancer.
Antibody-drug conjugates and their development remains a central theme in ongoing research within the realm of ovarian cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback